Save 20% on Press Releases and More with NNW Prime! Click to View Details
ThursdayJun 17, 2021 1:29 pm

NetworkNewsBreaks – Galileo Life Sciences Inc. (MDRM) Issues Telehealth Progress Update

Galileo Life Sciences (OTC: MDRM), a company strategically focused on the telehealth and telemedicine industry, today provided an update on its progress in providing next-generation telehealth services. Innovations in telehealth have enabled health care providers with superior technology, allowing them to diagnose, treat and monitor the state of their patients with greater efficiency. However, video conferencing, the key tool in most telehealth technologies, limits the ability of physicians to check the patients' vitals. Galileo Life Sciences, through its partnerships with various technology organizations, has established a unique platform that is connected with medical devices, which enables physicians to check patients'…

Continue Reading

ThursdayJun 17, 2021 1:23 pm

NetworkNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Continues Optimization of IntegraSyn(TM) to Increase Cannabinoid Yield

InMed Pharmaceuticals (NASDAQ: INM) is a clinical-stage company developing cannabinoid-based pharmaceutical drug candidates as well as manufacturing technologies for pharmaceutical-grade rare cannabinoids. The company announced that its continued optimization of IntegraSyn(TM) has increased the cannabinoid yield to a level of 5 g/L, further improving the economics of this proprietary manufacturing approach in advance of large-scale production. “We are very excited by these impressive yield levels that further validates the IntegraSyn manufacturing approach as a commercially viable solution for large-scale, pharmaceutical-grade GMP production of rare cannabinoids,” said Eric A. Adams, president and chief executive officer of InMed. “While we continue to…

Continue Reading

ThursdayJun 17, 2021 12:46 pm

NetworkNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Set for Inclusion in Russell 2000 Index

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, announced that the company will be added to the Russell 2000(R) Index, effective June 25, 2021, after the close of the U.S. equity markets. CNSP will be added following the annual reconstitution of the Russell stock indexes. According to the announcement, the Russell 2000 Index, which is a subset of the Russell 3000(R) Index, measures the performance of the small-cap segment of the equity market in the United States and includes an estimated 2,000…

Continue Reading

ThursdayJun 17, 2021 12:30 pm

NetworkNewsBreaks – Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) Announces Shipment of Initial Vape Cartridge Order to Alberta

Pure Extracts Technologies (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ), a plant-based extraction company focused on cannabis, hemp, functional mushrooms and the rapidly emerging psychedelic sector, has shipped its first order of vape cartridges to Alberta. The shipment was made through PRXTF’s wholly owned subsidiary, Pure Extracts Manufacturing Corp., which developed the proprietary one-gram, full-spectrum oil (“FSO”) vape cartridge. The cartridges were shipped to Alberta Gaming, Liquor & Cannabis (“AGLC”), the company’s distribution partner in the province. According to the announcement, consumer demand for Pure Extracts’ Pure Pulls branded 510 vape cartridges within the provincial markets is robust. The order consisted…

Continue Reading

ThursdayJun 17, 2021 11:35 am

NetworkNewsBreaks – The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) Announces Expanded East Coast Capacity to Meet Surging Demand

The Alkaline Water Company (NASDAQ: WTER) (CSE: WTER),the country’s largest independent alkaline water company, today announced that two of its leading suppliers have expanded their capacity by opening east coast facilities. According to the update, the company’s exclusive arrangements with these manufacturers will alleviate raw material concerns during its east coast expansion. Additionally, to meet anticipated demand, the company intends to add three new strategically located co-packers prior to the end of the third quarter. “As we position ourselves for continued growth, we continue to deploy assets that allow our production to exceed increased demand for Alkaline88(R),” said Ricky Wright,…

Continue Reading

ThursdayJun 17, 2021 10:53 am

NetworkNewsBreaks – XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Featured in Latest Episode of Bell2Bell Podcast

XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT), a life sciences technology accelerator, was featured in the Bell2Bell Podcast, a part of InvestorBrandNetwork’s (“IBN”) sustained effort to provide specialized content distribution via widespread syndication channels. XPhyto Therapeutics’ CEO and Director Hugh Rogers joined the latest episode to offer an operational update and discuss the company’s achievements and future plans. XPhyto Therapeutics recently secured European approval and launched an effective 25-minute polymerase chain reaction (“PCR”) test for COVID-19 (“Covid-ID Lab”), with an initial focus on the German market and several other initiatives underway. “This is an exciting time for the company.…

Continue Reading

ThursdayJun 17, 2021 10:42 am

NetworkNewsBreaks – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) CEO Featured Guest in Latest Stock2Me Podcast

Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF), a pharmaceutical company focused on developing clinical-stage compounds for diseases with unmet medical needs, announced that chairman and CEO Greg McKee was interviewed on the most recent episode of the Stock2Me Podcast. The podcast features a fascinating array of companies and individuals that are actively revolutionizing business practices within their respective markets. In the interview, McKee talked about the objective of TRYP, which is fundamentally to help patients, as well as identifying and bringing new therapies to patients. McKee also discussed the need for innovation in the psychedelics space and Tryp’s upcoming human clinical…

Continue Reading

ThursdayJun 17, 2021 10:33 am

NetworkNewsBreaks — VistaGen Therapeutics Inc. (NASDAQ: VTGN) Announces Plans to Join Russell 2000 Index

VistaGen Therapeutics (NASDAQ: VTGN), a biopharmaceutical company committed to developing and commercializing a new generation of medicines with the potential to go beyond the current standard of care for anxiety, depression and other central nervous system (“CNS”) disorders, will be added to the Russell 2000(R) Index effective Monday, June 28, 2021. The company will be added to the index at the conclusion of the 2021 Russell Indexes annual reconstitution. Investment managers and institutional investors often use the Russell U.S. Indexes, which are part of global index provider FTSE Russell, as a basis for index funds and as benchmarks for active…

Continue Reading

WednesdayJun 16, 2021 1:04 pm

NetworkNewsBreaks – Why American Cannabis Partners Is ‘One to Watch’

American Cannabis Partners (“ACP”) is a multistate cannabis company with a retail license and 560,000 square feet of licensed canopy space for cultivation. ACP’s strategy is to capture opportunities in real estate and licensing in states that have recently passed cannabis legalization legislation, thereby equipping the company to capitalize on federal interstate commerce opportunities. As a company that is focused on complementary business segments — real estate, acquisition and development of proprietary assets and ongoing cultivation operations, ACP is targeting expansion. A recent article reads, “American Cannabis Partners is pursuing additional growth in the cannabis sector through multiple planned initiatives.…

Continue Reading

WednesdayJun 16, 2021 12:55 pm

NetworkNewsBreaks – Knightscope Inc.’s ASRs Providing Multiple Security Advantages

Knightscope, a developer of advanced physical security technologies utilizing fully autonomous security robots (“ASRs”) focused on enhancing US security operations, offers a reasonable solution that could prove useful in various scenarios. “The company’s ASR offering is affordable, experienced and effective, and provides multiple security advantages,” reads a recent article. “The ASRs all feature the Knightscope Security Operations Center (“KSOC”) interface that provides real-time access to data around the clock, as well as 360-degree eye-level HD video streaming, people detection, facial recognition, automatic license plate recognition, thermal anomaly detection, and automatic signal detection, among others.” Knightscope has released three models —…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000